In an era where airborne threats like allergens and viruses disrupt daily life for millions, a small biotech innovator in Israel is quietly reshaping approaches to respiratory defense. Polyrizon Ltd.
New York City-based Commodore Capital boosted its stake in Relay Therapeutics (NASDAQ:RLAY) by nearly 3.7 million shares in ...